Apart from the glycosylation of ACE2 receptors that facilitates virus binding and the inflammatory process that increases insulin resistance, the hypoxia that is normally present in patients with COVID-19 is frequently accompanied by disordered cellular glucose metabolism. The gene discussed is INS; the disease is COVID-19.